Inflammatory bowel disease and risk of gastric, small bowel and colorectal cancer: a meta-analysis of 26 observational studies
Purpose The purpose of this meta-analysis was to assess the associations between inflammatory bowel disease (IBD) and risk of the gastric, small bowel and colorectal cancer. Methods We searched the PubMed and Web of Science for observational studies published before June 2020, and the quality of eac...
Uloženo v:
| Vydáno v: | Journal of cancer research and clinical oncology Ročník 147; číslo 4; s. 1077 - 1087 |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.04.2021
Springer Nature B.V |
| Témata: | |
| ISSN: | 0171-5216, 1432-1335, 1432-1335 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Purpose
The purpose of this meta-analysis was to assess the associations between inflammatory bowel disease (IBD) and risk of the gastric, small bowel and colorectal cancer.
Methods
We searched the PubMed and Web of Science for observational studies published before June 2020, and the quality of each included study was evaluated according to the Newcastle–Ottawa–Scale.
Results
Twenty-six studies comprising 531 449 IBD patients and more than 65 million reference individuals were included. Although IBD was significantly associated with 67% increased risk of the total gastric, small bowel and colorectal cancer. After stratifying by cancer location, IBD mainly increased the risk of intestinal cancer instead of gastric cancer. Furthermore, Crohn’s disease (CD) significantly increased the risk of both small bowel cancer and colorectal cancer, while ulcerative colitis (UC) only increased the risk of colorectal cancer. In subgroup analysis, associations between IBD and risk of total gastric, small bowel and colorectal cancer were similar between male and female, except for that male IBD patients but not female had a significantly higher risk of small bowel cancer. Additionally, IBD patients in different geographical areas had different associations with risk of various gastrointestinal tract cancers.
Conclusions
IBD is mainly associated with increased risk of cancers in the lower gastrointestinal tract, including small bowel cancer and colorectal cancer. Because studies about the association between IBD and risk of gastric cancer and the populations in Asia are limited, more observational studies are required in the future. |
|---|---|
| AbstractList | PurposeThe purpose of this meta-analysis was to assess the associations between inflammatory bowel disease (IBD) and risk of the gastric, small bowel and colorectal cancer.MethodsWe searched the PubMed and Web of Science for observational studies published before June 2020, and the quality of each included study was evaluated according to the Newcastle–Ottawa–Scale.ResultsTwenty-six studies comprising 531 449 IBD patients and more than 65 million reference individuals were included. Although IBD was significantly associated with 67% increased risk of the total gastric, small bowel and colorectal cancer. After stratifying by cancer location, IBD mainly increased the risk of intestinal cancer instead of gastric cancer. Furthermore, Crohn’s disease (CD) significantly increased the risk of both small bowel cancer and colorectal cancer, while ulcerative colitis (UC) only increased the risk of colorectal cancer. In subgroup analysis, associations between IBD and risk of total gastric, small bowel and colorectal cancer were similar between male and female, except for that male IBD patients but not female had a significantly higher risk of small bowel cancer. Additionally, IBD patients in different geographical areas had different associations with risk of various gastrointestinal tract cancers.ConclusionsIBD is mainly associated with increased risk of cancers in the lower gastrointestinal tract, including small bowel cancer and colorectal cancer. Because studies about the association between IBD and risk of gastric cancer and the populations in Asia are limited, more observational studies are required in the future. The purpose of this meta-analysis was to assess the associations between inflammatory bowel disease (IBD) and risk of the gastric, small bowel and colorectal cancer.PURPOSEThe purpose of this meta-analysis was to assess the associations between inflammatory bowel disease (IBD) and risk of the gastric, small bowel and colorectal cancer.We searched the PubMed and Web of Science for observational studies published before June 2020, and the quality of each included study was evaluated according to the Newcastle-Ottawa-Scale.METHODSWe searched the PubMed and Web of Science for observational studies published before June 2020, and the quality of each included study was evaluated according to the Newcastle-Ottawa-Scale.Twenty-six studies comprising 531 449 IBD patients and more than 65 million reference individuals were included. Although IBD was significantly associated with 67% increased risk of the total gastric, small bowel and colorectal cancer. After stratifying by cancer location, IBD mainly increased the risk of intestinal cancer instead of gastric cancer. Furthermore, Crohn's disease (CD) significantly increased the risk of both small bowel cancer and colorectal cancer, while ulcerative colitis (UC) only increased the risk of colorectal cancer. In subgroup analysis, associations between IBD and risk of total gastric, small bowel and colorectal cancer were similar between male and female, except for that male IBD patients but not female had a significantly higher risk of small bowel cancer. Additionally, IBD patients in different geographical areas had different associations with risk of various gastrointestinal tract cancers.RESULTSTwenty-six studies comprising 531 449 IBD patients and more than 65 million reference individuals were included. Although IBD was significantly associated with 67% increased risk of the total gastric, small bowel and colorectal cancer. After stratifying by cancer location, IBD mainly increased the risk of intestinal cancer instead of gastric cancer. Furthermore, Crohn's disease (CD) significantly increased the risk of both small bowel cancer and colorectal cancer, while ulcerative colitis (UC) only increased the risk of colorectal cancer. In subgroup analysis, associations between IBD and risk of total gastric, small bowel and colorectal cancer were similar between male and female, except for that male IBD patients but not female had a significantly higher risk of small bowel cancer. Additionally, IBD patients in different geographical areas had different associations with risk of various gastrointestinal tract cancers.IBD is mainly associated with increased risk of cancers in the lower gastrointestinal tract, including small bowel cancer and colorectal cancer. Because studies about the association between IBD and risk of gastric cancer and the populations in Asia are limited, more observational studies are required in the future.CONCLUSIONSIBD is mainly associated with increased risk of cancers in the lower gastrointestinal tract, including small bowel cancer and colorectal cancer. Because studies about the association between IBD and risk of gastric cancer and the populations in Asia are limited, more observational studies are required in the future. Purpose The purpose of this meta-analysis was to assess the associations between inflammatory bowel disease (IBD) and risk of the gastric, small bowel and colorectal cancer. Methods We searched the PubMed and Web of Science for observational studies published before June 2020, and the quality of each included study was evaluated according to the Newcastle–Ottawa–Scale. Results Twenty-six studies comprising 531 449 IBD patients and more than 65 million reference individuals were included. Although IBD was significantly associated with 67% increased risk of the total gastric, small bowel and colorectal cancer. After stratifying by cancer location, IBD mainly increased the risk of intestinal cancer instead of gastric cancer. Furthermore, Crohn’s disease (CD) significantly increased the risk of both small bowel cancer and colorectal cancer, while ulcerative colitis (UC) only increased the risk of colorectal cancer. In subgroup analysis, associations between IBD and risk of total gastric, small bowel and colorectal cancer were similar between male and female, except for that male IBD patients but not female had a significantly higher risk of small bowel cancer. Additionally, IBD patients in different geographical areas had different associations with risk of various gastrointestinal tract cancers. Conclusions IBD is mainly associated with increased risk of cancers in the lower gastrointestinal tract, including small bowel cancer and colorectal cancer. Because studies about the association between IBD and risk of gastric cancer and the populations in Asia are limited, more observational studies are required in the future. The purpose of this meta-analysis was to assess the associations between inflammatory bowel disease (IBD) and risk of the gastric, small bowel and colorectal cancer. We searched the PubMed and Web of Science for observational studies published before June 2020, and the quality of each included study was evaluated according to the Newcastle-Ottawa-Scale. Twenty-six studies comprising 531 449 IBD patients and more than 65 million reference individuals were included. Although IBD was significantly associated with 67% increased risk of the total gastric, small bowel and colorectal cancer. After stratifying by cancer location, IBD mainly increased the risk of intestinal cancer instead of gastric cancer. Furthermore, Crohn's disease (CD) significantly increased the risk of both small bowel cancer and colorectal cancer, while ulcerative colitis (UC) only increased the risk of colorectal cancer. In subgroup analysis, associations between IBD and risk of total gastric, small bowel and colorectal cancer were similar between male and female, except for that male IBD patients but not female had a significantly higher risk of small bowel cancer. Additionally, IBD patients in different geographical areas had different associations with risk of various gastrointestinal tract cancers. IBD is mainly associated with increased risk of cancers in the lower gastrointestinal tract, including small bowel cancer and colorectal cancer. Because studies about the association between IBD and risk of gastric cancer and the populations in Asia are limited, more observational studies are required in the future. |
| Author | Wan, Qianyi Wu, Yutao Wu, Xiao-Ting Cui, Yaping Xia, Lin Zhou, Yong Zhao, Rui Shen, Xiaoding Wang, Yong |
| Author_xml | – sequence: 1 givenname: Qianyi surname: Wan fullname: Wan, Qianyi organization: Department of Gastrointestinal Surgery, West China Hospital, Sichuan University – sequence: 2 givenname: Rui surname: Zhao fullname: Zhao, Rui organization: Department of Gastrointestinal Surgery, West China Hospital, Sichuan University – sequence: 3 givenname: Lin surname: Xia fullname: Xia, Lin organization: Department of Gastrointestinal Surgery, West China Hospital, Sichuan University – sequence: 4 givenname: Yutao surname: Wu fullname: Wu, Yutao organization: Department of Oral and Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University – sequence: 5 givenname: Yong surname: Zhou fullname: Zhou, Yong organization: Department of Gastrointestinal Surgery, West China Hospital, Sichuan University – sequence: 6 givenname: Yong surname: Wang fullname: Wang, Yong organization: Department of Gastrointestinal Surgery, West China Hospital, Sichuan University – sequence: 7 givenname: Yaping surname: Cui fullname: Cui, Yaping organization: Department of Gastrointestinal Surgery, West China Hospital, Sichuan University – sequence: 8 givenname: Xiaoding surname: Shen fullname: Shen, Xiaoding organization: Department of Gastrointestinal Surgery, West China Hospital, Sichuan University – sequence: 9 givenname: Xiao-Ting orcidid: 0000-0002-3996-868X surname: Wu fullname: Wu, Xiao-Ting email: wxt1@medmail.com.cn organization: Department of Gastrointestinal Surgery, West China Hospital, Sichuan University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33433655$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kktvVCEAhYmpsdPRP-DCkLhx4VXezLgxpvHRpIkbXRMuj5HKhQrcmtn0t5fpTH100Q0E-M7JAc4JOEo5OQCeY_QGIyTfVoQYJQMiaECUrcWAHoEF3m1hSvkRWCAs8cAJFsfgpNYL1NdckifgmFJGqeB8Aa7Pko96mnTLZQvH_NtFaEN1ujqok4Ul1J8we7jRtZVgXsM66RgP4A4wOebiTNMRGp2MK--ghpNretBJx20NdScnAuaxunKlW8h9H9Y22-DqU_DY61jds8O8BN8_ffx2-mU4__r57PTD-WA4w23QK-6IJCMeLUaWccm9R95bzI1g1I-SWCtGxpgga48kZd4RY9nIjZMcGUyX4P3e93IeJ2eNS63oqC5LmHTZqqyD-v8khR9qk68UxiuEV2vWHV4dHEr-Nbva1BSqcTHq5PJcFWFSEkHQmnf05T30Is-l37pTHCGxxpiKTr34N9KfLHd_04HVHjAl11qcVya02_frCUNUGKldDdS-BqrXQN3WoI9LQO5J79wfFNG9qHY4bVz5G_sB1Q3YI8X8 |
| CitedBy_id | crossref_primary_10_1155_2023_4098212 crossref_primary_10_1016_j_semcancer_2022_01_004 crossref_primary_10_1111_jog_14992 crossref_primary_10_3390_gastroent16020012 crossref_primary_10_3390_jcm12082843 crossref_primary_10_1093_ibd_izac096 crossref_primary_10_2174_0109298673314861240429072352 crossref_primary_10_1136_gutjnl_2025_335023 crossref_primary_10_1093_jncics_pkab096 crossref_primary_10_3389_fgene_2021_673180 crossref_primary_10_3389_fpubh_2022_892468 crossref_primary_10_3390_jcm12062432 crossref_primary_10_3389_fimmu_2023_1338918 crossref_primary_10_3390_biomedicines13030702 crossref_primary_10_3390_jcm13010148 crossref_primary_10_1016_j_jaut_2024_103321 crossref_primary_10_1007_s13555_022_00713_1 crossref_primary_10_1093_ecco_jcc_jjac187 crossref_primary_10_1007_s12672_025_02954_w crossref_primary_10_1016_j_semarthrit_2021_08_013 crossref_primary_10_23749_mdl_v113i6_13867 crossref_primary_10_3390_cells14010001 crossref_primary_10_3390_jcm14020608 crossref_primary_10_14309_ajg_0000000000002900 crossref_primary_10_4253_wjge_v16_i12_647 crossref_primary_10_1002_1878_0261_13143 crossref_primary_10_1053_j_gastro_2022_05_038 crossref_primary_10_3389_fimmu_2024_1339207 crossref_primary_10_3390_cancers16162901 crossref_primary_10_1093_ibd_izac241 crossref_primary_10_1021_acsabm_5c00394 crossref_primary_10_1089_jmf_2023_K_0154 crossref_primary_10_3390_genes14101844 crossref_primary_10_1007_s00384_021_03970_2 crossref_primary_10_1016_j_exger_2025_112861 crossref_primary_10_3389_fonc_2025_1564575 crossref_primary_10_1007_s10552_024_01858_4 crossref_primary_10_1007_s11739_023_03320_w crossref_primary_10_1080_10408363_2022_2038075 crossref_primary_10_1186_s12916_023_03096_y crossref_primary_10_3389_fimmu_2023_1115552 crossref_primary_10_1097_JS9_0000000000002219 crossref_primary_10_4251_wjgo_v15_i8_1317 crossref_primary_10_15557_PiMR_2024_0058 crossref_primary_10_1016_j_annonc_2022_02_226 crossref_primary_10_1136_flgastro_2025_103136 |
| Cites_doi | 10.1136/gutjnl-2020-320945 10.1093/ecco-jcc/jjz199 10.1002/ijc.30183 10.1007/s10654-010-9491-z 10.1155/2016/1632439 10.1016/j.immuni.2019.03.017 10.1038/nri3661 10.1038/ajg.2013.249 10.3109/00365521.2013.846402 10.3109/00365521.2014.989538 10.1158/1055-9965.EPI-10-1281 10.1093/ibd/izx046 10.1097/MIB.0000000000001240 10.1053/j.gastro.2005.12.037 10.3748/wjg.v19.i48.9359 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z 10.1136/bmj.327.7414.557 10.1016/j.cgh.2017.06.051 10.1111/j.1365-2036.2004.01858.x 10.1093/ecco-jcc/jjz058 10.1097/MIB.0b013e31828029c0 10.1136/gutjnl-2019-318484 10.1016/S0140-6736(16)31711-1 10.1097/MIB.0000000000000236 10.1016/j.ccr.2009.01.001 10.1007/s00535-016-1199-8 10.1093/ecco-jcc/jjx040 10.1136/bmj.b2535 10.1016/0197-2456(86)90046-2 10.1053/j.gastro.2012.04.054 10.1016/j.crohns.2013.04.003 10.1002/cncr.25731 10.1136/gutjnl-2018-317294 10.1001/jama.283.15.2008 10.1111/apt.15701 10.1016/j.cgh.2013.03.034 10.1136/bmj.j3951 10.1007/s10620-011-1632-z 10.1038/ajg.2016.304 10.1038/ni.3384 |
| ContentType | Journal Article |
| Copyright | The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021 Copyright Springer Nature B.V. Apr 2021 The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021 2021 |
| Copyright_xml | – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021 – notice: Copyright Springer Nature B.V. Apr 2021 – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021 2021 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TO 7X7 7XB 88E 8AO 8C1 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 K9. M0S M1P M2O MBDVC PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM |
| DOI | 10.1007/s00432-020-03496-0 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Research Library Research Library (Corporate) Proquest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Research Library Prep MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: PROQUEST url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1432-1335 |
| EndPage | 1087 |
| ExternalDocumentID | PMC11801894 33433655 10_1007_s00432_020_03496_0 |
| Genre | Meta-Analysis Journal Article |
| GrantInformation_xml | – fundername: Sichuan Province Science and Technology Support Program grantid: 2018SZ0189 funderid: http://dx.doi.org/10.13039/100012542 – fundername: Sichuan Province Science and Technology Support Program grantid: 2018SZ0189 |
| GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C -~X .55 .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 1SB 2.D 203 28- 29K 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 3V. 4.4 406 408 409 40D 40E 53G 5QI 5RE 5VS 67Z 6NX 78A 7X7 88E 8AO 8C1 8FI 8FJ 8G5 8UJ 95- 95. 95~ 96X AAAVM AABHQ AAHNG AAIAL AAJKR AAJSJ AAKKN AANXM AANZL AARHV AARTL AATVU AAUYE AAWCG AAYIU AAYOK AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABEEZ ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMOR ABMQK ABNWP ABPLI ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACACY ACBXY ACGFS ACHSB ACHVE ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACUDM ACULB ACZOJ ADBBV ADHHG ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFFNX AFGXO AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BVXVI C24 C6C CAG CCPQU COF CS3 CSCUP D-I DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GROUPED_DOAJ GRRUI GUQSH GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M2O M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT5 Q2X QOK QOR QOS R89 R9I RHV RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 X7M YLTOR Z45 Z7U Z82 Z83 Z87 Z8O Z8V Z8W Z91 ZGI ZMTXR ZOVNA ZXP ~EX ~KM AAFWJ AASML AAYXX ABDBE ABFSG ACSTC ADHKG AEZWR AFFHD AFHIU AFPKN AGQPQ AHPBZ AHWEU AIXLP AYFIA CITATION PHGZM PHGZT PJZUB PPXIY RPM CGR CUY CVF ECM EIF NPM 7TO 7XB 8FK H94 K9. MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM |
| ID | FETCH-LOGICAL-c541t-a85e272b1bd10d4575ff0ffd15c643fb72dd6b444629f0734fe2cd4b5ce750c13 |
| IEDL.DBID | 7X7 |
| ISICitedReferencesCount | 51 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000608139100005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0171-5216 1432-1335 |
| IngestDate | Tue Nov 04 02:03:32 EST 2025 Sun Nov 09 11:02:43 EST 2025 Sat Oct 18 22:43:47 EDT 2025 Sun Jul 20 01:30:39 EDT 2025 Tue Nov 18 22:20:53 EST 2025 Sat Nov 29 02:55:35 EST 2025 Fri Feb 21 02:48:52 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | Inflammatory bowel disease Gastrointestinal tract cancer Meta-analysis |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c541t-a85e272b1bd10d4575ff0ffd15c643fb72dd6b444629f0734fe2cd4b5ce750c13 |
| Notes | ObjectType-Article-1 ObjectType-Evidence Based Healthcare-3 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-3996-868X |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/11801894 |
| PMID | 33433655 |
| PQID | 2500691136 |
| PQPubID | 47182 |
| PageCount | 11 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11801894 proquest_miscellaneous_2477262095 proquest_journals_2500691136 pubmed_primary_33433655 crossref_citationtrail_10_1007_s00432_020_03496_0 crossref_primary_10_1007_s00432_020_03496_0 springer_journals_10_1007_s00432_020_03496_0 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-04-01 |
| PublicationDateYYYYMMDD | 2021-04-01 |
| PublicationDate_xml | – month: 04 year: 2021 text: 2021-04-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Berlin/Heidelberg |
| PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
| PublicationTitle | Journal of cancer research and clinical oncology |
| PublicationTitleAbbrev | J Cancer Res Clin Oncol |
| PublicationTitleAlternate | J Cancer Res Clin Oncol |
| PublicationYear | 2021 |
| Publisher | Springer Berlin Heidelberg Springer Nature B.V |
| Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
| References | Bernstein, Blanchard, Kliewer, Wajda (CR3) 2001; 91 Stroup, Berlin, Morton, Olkin, Williamson, Rennie, Moher, Becker, Sipe, Thacker (CR38) 2000; 283 Bojesen, Riis, Hogdall, Nielsen, Jess (CR4) 2017; 15 Moher, Liberati, Tetzlaff, Altman (CR28) 2009; 339 Francescone, Hou, Grivennikov (CR8) 2015; 21 Jung, Han, Park, Kim, Cheon (CR17) 2017; 11 Lee, Park, Yang, Ye, Kim, Kim, Soh, Lee, Bae, Lee, Yang, Kim, Byeon, Myung, Yoon, Yu, Kim (CR23) 2015; 50 Neurath (CR30) 2014; 14 Hovde, Hoivik, Henriksen, Solberg, Smastuen, Moum (CR13) 2017; 11 Kappelman, Farkas, Long, Erichsen, Sandler, Sorensen, Baron (CR19) 2014; 12 Lutgens, van Oijen, van der Heijden, Vleggaar, Siersema, Oldenburg (CR25) 2013; 19 van den Heuvel, Wintjens, Jeuring, Wassink, Romberg-Camps, Oostenbrug, Sanduleanu, Hameeteman, Zeegers, Masclee, Jonkers, Pierik (CR41) 2016; 139 DerSimonian, Laird (CR7) 1986; 7 Herrinton, Liu, Levin, Allison, Lewis, Velayos (CR11) 2012; 143 de Barrios, Sanchez-Moral, Cortes, Ninfali, Profitos-Peleja, Martinez-Campanario, Siles, Del Campo, Fernandez-Acenero, Darling, Castells, Maurel, Salas, Dean, Postigo (CR6) 2019; 68 Mosher, Brown, Weideman, Crook, Cipher, Spechler, Feagins (CR29) 2018; 24 Axelrad, Olen, Sachs, Erichsen, Pedersen, Halfvarson, Askling, Ekbom, Sorensen, Ludvigsson (CR2) 2020 Cheddani, Dauchet, Fumery, Charpentier, Marie Bouvier, Dupas, Pariente, Peyrin-Biroulet, Savoye, Gower-Rousseau (CR5) 2016; 111 Shaukat, Virnig, Howard, Sitaraman, Liff, Lederle (CR34) 2011; 20 Grivennikov, Karin, Terzic, Mucida, Yu, Vallabhapurapu, Scheller, Rose-John, Cheroutre, Eckmann, Karin (CR10) 2009; 15 Lasry, Zinger, Ben-Neriah (CR22) 2016; 17 Algaba, Guerra, Castano, de la Poza, Castellano, Lopez, Bermejo (CR1) 2013; 19 So, Tang, Leung, Li, Lo, Wong, Sze, Leung, Tsang, Shan, Chan, Lam, Hui, Chow, Lam, Lam, Lee, Lo, Tang, Wong, Wu, Chan, Sung, Harbord, Ng (CR36) 2017; 23 Olen, Askling, Sachs, Frumento, Neovius, Smedby, Ekbom, Malmborg, Ludvigsson (CR32) 2017; 358 Svrcek, Borralho Nunes, Villanacci, Beaugerie, Rogler, De Hertogh, Tripathi, Feakins, H. E. group (CR39) 2018; 12 Higgins, Thompson, Deeks, Altman (CR12) 2003; 327 Loo, Vutcovici, Bitton, Lakatos, Azoulay, Suissa, Brassard (CR24) 2019; 13 Samadder, Mukherjee, Huang, Ahn, Rennert, Greenson, Rennert, Gruber (CR33) 2011; 117 Jess, Loftus, Velayos, Harmsen, Zinsmeister, Smyrk, Schleck, Tremaine, Melton, Munkholm, Sandborn (CR15) 2006; 130 Mark-Christensen, Erichsen, Veres, Laurberg, Sorensen (CR27) 2020; 14 Jess, Winther, Munkholm, Langholz, Binder (CR14) 2004; 19 Manninen, Karvonen, Huhtala, Aitola, Hyoty, Nieminen, Hemminki, Collin (CR26) 2013; 7 Wheat, Clark-Snustad, Devine, Grembowski, Thornton, Ko (CR42) 2016; 2016 Jess, Horvath-Puho, Fallingborg, Rasmussen, Jacobsen (CR16) 2013; 108 Wilson, Furlano, Jick, Meier (CR43) 2016; 51 Torres, Mehandru, Colombel, Peyrin-Biroulet (CR40) 2017; 389 Jussila, Virta, Pukkala, Farkkila (CR18) 2013; 48 Friedrich, Pohin, Powrie (CR9) 2019; 50 Stang (CR37) 2010; 25 King, Reulen, Thomas, Chandan, Thayakaran, Subramanian, Gokhale, Bhala, Nirantharakumar, Adderley, Trudgill (CR20) 2020; 51 Shaukat, Virnig, Salfiti, Howard, Sitaraman, Liff (CR35) 2011; 56 Ng, Shi, Hamidi, Underwood, Tang, Benchimol, Panaccione, Ghosh, Wu, Chan, Sung, Kaplan (CR31) 2018; 390 Lamb, Kennedy, Raine, Hendy, Smith, Limdi, Hayee, Lomer, Parkes, Selinger, Barrett, Davies, Bennett, Gittens, Dunlop, Faiz, Fraser, Garrick, Johnston, Parkes, Sanderson, Terry, Gaya, Iqbal, Taylor, Smith, Brookes, Hansen, Hawthorne (CR21) 2019; 68 M Friedrich (3496_CR9) 2019; 50 O de Barrios (3496_CR6) 2019; 68 A Lasry (3496_CR22) 2016; 17 T Jess (3496_CR14) 2004; 19 J So (3496_CR36) 2017; 23 CL Wheat (3496_CR42) 2016; 2016 A Shaukat (3496_CR34) 2011; 20 O Hovde (3496_CR13) 2017; 11 RD Bojesen (3496_CR4) 2017; 15 CN Bernstein (3496_CR3) 2001; 91 AR Mark-Christensen (3496_CR27) 2020; 14 MF Neurath (3496_CR30) 2014; 14 T Jess (3496_CR15) 2006; 130 SC Ng (3496_CR31) 2018; 390 JC Wilson (3496_CR43) 2016; 51 R Francescone (3496_CR8) 2015; 21 HS Lee (3496_CR23) 2015; 50 CA Mosher (3496_CR29) 2018; 24 CA Lamb (3496_CR21) 2019; 68 YS Jung (3496_CR17) 2017; 11 MD Kappelman (3496_CR19) 2014; 12 H Cheddani (3496_CR5) 2016; 111 S Grivennikov (3496_CR10) 2009; 15 MW Lutgens (3496_CR25) 2013; 19 O Olen (3496_CR32) 2017; 358 M Svrcek (3496_CR39) 2018; 12 SY Loo (3496_CR24) 2019; 13 A Stang (3496_CR37) 2010; 25 A Shaukat (3496_CR35) 2011; 56 JE Axelrad (3496_CR2) 2020 J Torres (3496_CR40) 2017; 389 R DerSimonian (3496_CR7) 1986; 7 DF Stroup (3496_CR38) 2000; 283 P Manninen (3496_CR26) 2013; 7 A Algaba (3496_CR1) 2013; 19 T Jess (3496_CR16) 2013; 108 TR van den Heuvel (3496_CR41) 2016; 139 LJ Herrinton (3496_CR11) 2012; 143 JP Higgins (3496_CR12) 2003; 327 D King (3496_CR20) 2020; 51 A Jussila (3496_CR18) 2013; 48 NJ Samadder (3496_CR33) 2011; 117 D Moher (3496_CR28) 2009; 339 |
| References_xml | – volume: 68 start-page: s1 issue: Suppl 3 year: 2019 end-page: s106 ident: CR21 article-title: British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults publication-title: Gut – year: 2020 ident: CR2 article-title: Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden publication-title: Gut doi: 10.1136/gutjnl-2020-320945 – volume: 20 start-page: 1120 issue: 6 year: 2011 end-page: 1123 ident: CR34 article-title: Crohn's disease and small bowel adenocarcinoma: a population-based case-control study publication-title: Cancer Epidemiol Biomarkers Prev – volume: 13 start-page: 1302 issue: 10 year: 2019 end-page: 1310 ident: CR24 article-title: Risk of malignant cancers in inflammatory bowel disease publication-title: J Crohns Colitis – volume: 51 start-page: 922 issue: 10 year: 2020 end-page: 934 ident: CR20 article-title: Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000–2018 publication-title: Aliment Pharmacol Ther – volume: 19 start-page: 789 issue: 4 year: 2013 end-page: 799 ident: CR25 article-title: Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies publication-title: Inflamm Bowel Dis – volume: 111 start-page: 1428 issue: 10 year: 2016 end-page: 1436 ident: CR5 article-title: Cancer in elderly onset inflammatory bowel disease: a population-based study publication-title: Am J Gastroenterol – volume: 12 start-page: 265 issue: 2 year: 2014 end-page: 273 e261 ident: CR19 article-title: Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation publication-title: Clin Gastroenterol Hepatol – volume: 14 start-page: 630 issue: 5 year: 2020 end-page: 635 ident: CR27 article-title: Extracolonic cancer risk after total colectomy for inflammatory bowel disease: A population-based cohort study publication-title: J Crohns Colitis doi: 10.1093/ecco-jcc/jjz199 – volume: 117 start-page: 1640 issue: 8 year: 2011 end-page: 1648 ident: CR33 article-title: Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use publication-title: Cancer – volume: 7 start-page: e551 issue: 11 year: 2013 end-page: 557 ident: CR26 article-title: The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years publication-title: J Crohns Colitis – volume: 389 start-page: 1741 issue: 10080 year: 2017 end-page: 1755 ident: CR40 article-title: Crohn's disease publication-title: Lancet – volume: 11 start-page: 954 issue: 8 year: 2017 end-page: 962 ident: CR17 article-title: Cancer risk in the early stages of inflammatory bowel disease in korean patients: a nationwide population-based study publication-title: J Crohns Colitis – volume: 283 start-page: 2008 issue: 15 year: 2000 end-page: 2012 ident: CR38 article-title: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group publication-title: JAMA – volume: 15 start-page: 1900 issue: 12 year: 2017 end-page: 1907 e1902 ident: CR4 article-title: Inflammatory bowel disease and small bowel cancer risk, clinical characteristics, and histopathology: a population-based study publication-title: Clin Gastroenterol Hepatol – volume: 327 start-page: 557 issue: 7414 year: 2003 end-page: 560 ident: CR12 article-title: Measuring inconsistency in meta-analyses publication-title: BMJ – volume: 15 start-page: 103 issue: 2 year: 2009 end-page: 113 ident: CR10 article-title: IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer publication-title: Cancer Cell – volume: 19 start-page: 287 issue: 3 year: 2004 end-page: 293 ident: CR14 article-title: Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark publication-title: Aliment Pharmacol Ther – volume: 50 start-page: 992 issue: 4 year: 2019 end-page: 1006 ident: CR9 article-title: Cytokine networks in the pathophysiology of inflammatory bowel disease publication-title: Immunity – volume: 21 start-page: 409 issue: 2 year: 2015 end-page: 418 ident: CR8 article-title: Cytokines, IBD, and colitis-associated cancer publication-title: Inflamm Bowel Dis – volume: 358 start-page: j3951 year: 2017 ident: CR32 article-title: Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964–2014 publication-title: BMJ – volume: 23 start-page: 2061 issue: 11 year: 2017 end-page: 2068 ident: CR36 article-title: Cancer risk in 2621 chinese patients with inflammatory bowel disease: a population-based cohort study publication-title: Inflamm Bowel Dis – volume: 17 start-page: 230 issue: 3 year: 2016 end-page: 240 ident: CR22 article-title: Inflammatory networks underlying colorectal cancer publication-title: Nat Immunol – volume: 11 start-page: 571 issue: 5 year: 2017 end-page: 577 ident: CR13 article-title: Malignancies in patients with inflammatory bowel disease: results from 20 years of follow-up in the IBSEN study publication-title: J Crohns Colitis – volume: 390 start-page: 2769 issue: 10114 year: 2018 end-page: 2778 ident: CR31 article-title: Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies publication-title: Lancet – volume: 12 start-page: 1486 issue: 12 year: 2018 end-page: 1498 ident: CR39 article-title: Clinicopathological and molecular specificities of inflammatory bowel disease-related colorectal neoplastic lesions: the role of inflammation publication-title: J Crohns Colitis – volume: 139 start-page: 1270 issue: 6 year: 2016 end-page: 1280 ident: CR41 article-title: Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort publication-title: Int J Cancer – volume: 143 start-page: 382 issue: 2 year: 2012 end-page: 389 ident: CR11 article-title: Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010 publication-title: Gastroenterology – volume: 108 start-page: 1869 issue: 12 year: 2013 end-page: 1876 ident: CR16 article-title: Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study publication-title: Am J Gastroenterol – volume: 339 start-page: b2535 year: 2009 ident: CR28 article-title: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement publication-title: BMJ – volume: 50 start-page: 188 issue: 2 year: 2015 end-page: 196 ident: CR23 article-title: The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea publication-title: Scand J Gastroenterol – volume: 130 start-page: 1039 issue: 4 year: 2006 end-page: 1046 ident: CR15 article-title: Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota publication-title: Gastroenterology – volume: 56 start-page: 2378 issue: 8 year: 2011 end-page: 2383 ident: CR35 article-title: Is inflammatory bowel disease an important risk factor among older persons with colorectal cancer in the United States? A population-based case-control study publication-title: Dig Dis Sci – volume: 2016 start-page: 1632439 year: 2016 ident: CR42 article-title: Worldwide incidence of colorectal cancer, leukemia, and lymphoma in inflammatory bowel disease: an updated systematic review and meta-analysis publication-title: Gastroenterol Res Pract – volume: 51 start-page: 1050 issue: 11 year: 2016 end-page: 1062 ident: CR43 article-title: A population-based study examining the risk of malignancy in patients diagnosed with inflammatory bowel disease publication-title: J Gastroenterol – volume: 68 start-page: 2129 issue: 12 year: 2019 end-page: 2141 ident: CR6 article-title: ZEB1 promotes inflammation and progression towards inflammation-driven carcinoma through repression of the DNA repair glycosylase MPG in epithelial cells publication-title: Gut – volume: 19 start-page: 9359 issue: 48 year: 2013 end-page: 9365 ident: CR1 article-title: Risk of cancer, with special reference to extra-intestinal malignancies, in patients with inflammatory bowel disease publication-title: World J Gastroenterol – volume: 7 start-page: 177 issue: 3 year: 1986 end-page: 188 ident: CR7 article-title: Meta-analysis in clinical trials publication-title: Control Clin Trials – volume: 48 start-page: 1405 issue: 12 year: 2013 end-page: 1413 ident: CR18 article-title: Malignancies in patients with inflammatory bowel disease: a nationwide register study in Finland publication-title: Scand J Gastroenterol – volume: 24 start-page: 617 issue: 3 year: 2018 end-page: 623 ident: CR29 article-title: Incidence of colorectal cancer and extracolonic cancers in veteran patients with inflammatory bowel disease publication-title: Inflamm Bowel Dis – volume: 14 start-page: 329 issue: 5 year: 2014 end-page: 342 ident: CR30 article-title: Cytokines in inflammatory bowel disease publication-title: Nat Rev Immunol – volume: 25 start-page: 603 issue: 9 year: 2010 end-page: 605 ident: CR37 article-title: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses publication-title: Eur J Epidemiol – volume: 91 start-page: 854 issue: 4 year: 2001 end-page: 862 ident: CR3 article-title: Cancer risk in patients with inflammatory bowel disease: a population-based study publication-title: Cancer – volume: 139 start-page: 1270 issue: 6 year: 2016 ident: 3496_CR41 publication-title: Int J Cancer doi: 10.1002/ijc.30183 – volume: 25 start-page: 603 issue: 9 year: 2010 ident: 3496_CR37 publication-title: Eur J Epidemiol doi: 10.1007/s10654-010-9491-z – volume: 2016 start-page: 1632439 year: 2016 ident: 3496_CR42 publication-title: Gastroenterol Res Pract doi: 10.1155/2016/1632439 – volume: 50 start-page: 992 issue: 4 year: 2019 ident: 3496_CR9 publication-title: Immunity doi: 10.1016/j.immuni.2019.03.017 – volume: 14 start-page: 329 issue: 5 year: 2014 ident: 3496_CR30 publication-title: Nat Rev Immunol doi: 10.1038/nri3661 – volume: 108 start-page: 1869 issue: 12 year: 2013 ident: 3496_CR16 publication-title: Am J Gastroenterol doi: 10.1038/ajg.2013.249 – volume: 48 start-page: 1405 issue: 12 year: 2013 ident: 3496_CR18 publication-title: Scand J Gastroenterol doi: 10.3109/00365521.2013.846402 – volume: 50 start-page: 188 issue: 2 year: 2015 ident: 3496_CR23 publication-title: Scand J Gastroenterol doi: 10.3109/00365521.2014.989538 – volume: 11 start-page: 571 issue: 5 year: 2017 ident: 3496_CR13 publication-title: J Crohns Colitis – volume: 20 start-page: 1120 issue: 6 year: 2011 ident: 3496_CR34 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-10-1281 – volume: 24 start-page: 617 issue: 3 year: 2018 ident: 3496_CR29 publication-title: Inflamm Bowel Dis doi: 10.1093/ibd/izx046 – volume: 23 start-page: 2061 issue: 11 year: 2017 ident: 3496_CR36 publication-title: Inflamm Bowel Dis doi: 10.1097/MIB.0000000000001240 – volume: 130 start-page: 1039 issue: 4 year: 2006 ident: 3496_CR15 publication-title: Gastroenterology doi: 10.1053/j.gastro.2005.12.037 – volume: 19 start-page: 9359 issue: 48 year: 2013 ident: 3496_CR1 publication-title: World J Gastroenterol doi: 10.3748/wjg.v19.i48.9359 – volume: 14 start-page: 630 issue: 5 year: 2020 ident: 3496_CR27 publication-title: J Crohns Colitis doi: 10.1093/ecco-jcc/jjz199 – volume: 390 start-page: 2769 issue: 10114 year: 2018 ident: 3496_CR31 publication-title: Lancet – volume: 91 start-page: 854 issue: 4 year: 2001 ident: 3496_CR3 publication-title: Cancer doi: 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z – volume: 327 start-page: 557 issue: 7414 year: 2003 ident: 3496_CR12 publication-title: BMJ doi: 10.1136/bmj.327.7414.557 – volume: 15 start-page: 1900 issue: 12 year: 2017 ident: 3496_CR4 publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2017.06.051 – volume: 19 start-page: 287 issue: 3 year: 2004 ident: 3496_CR14 publication-title: Aliment Pharmacol Ther doi: 10.1111/j.1365-2036.2004.01858.x – volume: 13 start-page: 1302 issue: 10 year: 2019 ident: 3496_CR24 publication-title: J Crohns Colitis doi: 10.1093/ecco-jcc/jjz058 – volume: 19 start-page: 789 issue: 4 year: 2013 ident: 3496_CR25 publication-title: Inflamm Bowel Dis doi: 10.1097/MIB.0b013e31828029c0 – volume: 12 start-page: 1486 issue: 12 year: 2018 ident: 3496_CR39 publication-title: J Crohns Colitis – volume: 68 start-page: s1 issue: Suppl 3 year: 2019 ident: 3496_CR21 publication-title: Gut doi: 10.1136/gutjnl-2019-318484 – volume: 389 start-page: 1741 issue: 10080 year: 2017 ident: 3496_CR40 publication-title: Lancet doi: 10.1016/S0140-6736(16)31711-1 – volume: 21 start-page: 409 issue: 2 year: 2015 ident: 3496_CR8 publication-title: Inflamm Bowel Dis doi: 10.1097/MIB.0000000000000236 – volume: 15 start-page: 103 issue: 2 year: 2009 ident: 3496_CR10 publication-title: Cancer Cell doi: 10.1016/j.ccr.2009.01.001 – volume: 51 start-page: 1050 issue: 11 year: 2016 ident: 3496_CR43 publication-title: J Gastroenterol doi: 10.1007/s00535-016-1199-8 – volume: 11 start-page: 954 issue: 8 year: 2017 ident: 3496_CR17 publication-title: J Crohns Colitis doi: 10.1093/ecco-jcc/jjx040 – volume: 339 start-page: b2535 year: 2009 ident: 3496_CR28 publication-title: BMJ doi: 10.1136/bmj.b2535 – year: 2020 ident: 3496_CR2 publication-title: Gut doi: 10.1136/gutjnl-2020-320945 – volume: 7 start-page: 177 issue: 3 year: 1986 ident: 3496_CR7 publication-title: Control Clin Trials doi: 10.1016/0197-2456(86)90046-2 – volume: 143 start-page: 382 issue: 2 year: 2012 ident: 3496_CR11 publication-title: Gastroenterology doi: 10.1053/j.gastro.2012.04.054 – volume: 7 start-page: e551 issue: 11 year: 2013 ident: 3496_CR26 publication-title: J Crohns Colitis doi: 10.1016/j.crohns.2013.04.003 – volume: 117 start-page: 1640 issue: 8 year: 2011 ident: 3496_CR33 publication-title: Cancer doi: 10.1002/cncr.25731 – volume: 68 start-page: 2129 issue: 12 year: 2019 ident: 3496_CR6 publication-title: Gut doi: 10.1136/gutjnl-2018-317294 – volume: 283 start-page: 2008 issue: 15 year: 2000 ident: 3496_CR38 publication-title: JAMA doi: 10.1001/jama.283.15.2008 – volume: 51 start-page: 922 issue: 10 year: 2020 ident: 3496_CR20 publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.15701 – volume: 12 start-page: 265 issue: 2 year: 2014 ident: 3496_CR19 publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2013.03.034 – volume: 358 start-page: j3951 year: 2017 ident: 3496_CR32 publication-title: BMJ doi: 10.1136/bmj.j3951 – volume: 56 start-page: 2378 issue: 8 year: 2011 ident: 3496_CR35 publication-title: Dig Dis Sci doi: 10.1007/s10620-011-1632-z – volume: 111 start-page: 1428 issue: 10 year: 2016 ident: 3496_CR5 publication-title: Am J Gastroenterol doi: 10.1038/ajg.2016.304 – volume: 17 start-page: 230 issue: 3 year: 2016 ident: 3496_CR22 publication-title: Nat Immunol doi: 10.1038/ni.3384 |
| SSID | ssj0017572 |
| Score | 2.516397 |
| SecondaryResourceType | review_article |
| Snippet | Purpose
The purpose of this meta-analysis was to assess the associations between inflammatory bowel disease (IBD) and risk of the gastric, small bowel and... The purpose of this meta-analysis was to assess the associations between inflammatory bowel disease (IBD) and risk of the gastric, small bowel and colorectal... PurposeThe purpose of this meta-analysis was to assess the associations between inflammatory bowel disease (IBD) and risk of the gastric, small bowel and... |
| SourceID | pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1077 |
| SubjectTerms | Cancer Research Colorectal cancer Colorectal carcinoma Colorectal Neoplasms - etiology Colorectal Neoplasms - pathology Crohn's disease Gastric cancer Gastrointestinal tract Hematology Humans Inflammatory bowel disease Inflammatory bowel diseases Inflammatory Bowel Diseases - complications Internal Medicine Intestinal Neoplasms - etiology Intestinal Neoplasms - pathology Intestine, Small - pathology Medicine Medicine & Public Health Meta-analysis Observational studies Observational Studies as Topic Oncology Original Article – Cancer Research Original – Cancer Research Prognosis Risk Factors Small intestine Stomach Neoplasms - etiology Stomach Neoplasms - pathology Ulcerative colitis |
| SummonAdditionalLinks | – databaseName: SpringerLink Journals dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqUiEu5Q2hBRmJG7UUv5KYG6qoqNRWFY-qt8jPUmk3QZttufHbGXudoKWABGeP49fYnsk3_gahV7riwnjVEMmVJEIyT5QxhgivtKbK2joh-GdH9clJc36uTvOjsGGMdh8hyXRST4_dEnscie5OYjkn4KjfguuuiQkbPnw8m7CDWqaUTZEIBtwsWuWnMr__xvp1dMPGvBkq-Qtemq6hg7v_N4B7aDubnfjtSk_uow3fPUC3jzOw_hB9P-wC6MY8Ye7Y9N_8DGfsBuvO4RiBjvuAL3TM82H38DDXs1kWjAKR_DoentCIjYq0eIM1nvulJjrTnsTqrMK9mf4Dg-ywCmN8hD4fvPu0_57k1AzESkGXRDfSs5oZahwtnQCbL4QyBEelBRMnmJo5VxkBviZTAU4RETyzThhpPZgolvLHaLPrO_8U4eCd9BUrbR2U8I3Tyjpe87qJ5GSUuQLRcYVam3nLY_qMWTsxLqeJbWFi2zSxbVmg11OdryvWjr9K744L3-YdPLRgGpaVihlvCvRyKoa9FwEV3fn-CmQE-CbQdSUL9GSlJ1NznAvOKwklzZoGTQKR13u9pLv8kvi9IysfbZQo0N6oSD_79edhPPs38R10h8X4nBSFtIs2l4sr_xxt2evl5bB4kbbUDxbwG3M priority: 102 providerName: Springer Nature |
| Title | Inflammatory bowel disease and risk of gastric, small bowel and colorectal cancer: a meta-analysis of 26 observational studies |
| URI | https://link.springer.com/article/10.1007/s00432-020-03496-0 https://www.ncbi.nlm.nih.gov/pubmed/33433655 https://www.proquest.com/docview/2500691136 https://www.proquest.com/docview/2477262095 https://pubmed.ncbi.nlm.nih.gov/PMC11801894 |
| Volume | 147 |
| WOSCitedRecordID | wos000608139100005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAVX databaseName: SpringerLink Journals customDbUrl: eissn: 1432-1335 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017572 issn: 0171-5216 databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3daxQxEA_aivjid3W1lgi-2eAmm_2IL6KlRcGepWq5tyWfWrjbrXdXffNvdyaX23IW--JLYMmEbJjJZCYz-Q0hL3RVSONVw8pClUyWwjNljGHSK625sraOEfyTj_Vo1IzH6ihduM1TWuVKJ0ZF7XqLd-Sv4KjOK4UVSN6c_WBYNQqjq6mExnWyiWWzUc7r8eBwwckYizchJAw4XLxKj2bi07mIRcfQeYqY6SxfP5guWZuXkyb_ipzGA-ngzv8u5S65nUxR-nYpO_fINd_dJzcPU7D9Afn9oQsgL9MYh6em_-UnNMVzqO4cxax02gf6TWPtD7tL51M9mSRCJEBAbFSoMIlF4Zq9pppO_UIznaBQcLioaG-Gu2GgnS9TGx-Srwf7X_bes1SugdlS8gXTTelFLQw3judOgh0YQh6C46UFsyeYWjhXGQn-p1ABNIsMXlgnTWk9mC2WF1tko-s7_5jQ4F3pK5HbOijpG6eVdUVd1A0ClnHhMsJXvGptwjLHkhqTdkBhjvxtgb9t5G-bZ-TlMOZsieRxJfX2indt2tXz9oJxGXk-dMN-xCCL7nx_DjQS_BX4dVVm5NFSYobpikIWRVVCT7MmSwMBYn2v93Sn3yPmNyL18UbJjOyuxO7iv_69jCdXL-MpuSUwRydmIm2TjcXs3D8jN-zPxel8thM3U2wbaJs9vkM23-2Pjo7h61B8gvb488kfkX0qxQ |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgoAL78dCASPBiVokjp3ESAghoOqq28KhoN5SP6HSblJ2t1Rc-En8RjzeJNVS0VsPnD3ZxNlvPJ7M528Anqk849rJkopMCsoFc1RqrSl3UqlUGlPECv6XUbGzU-7tyU8r8Ls7C4O0ym5NjAu1bQx-I38ZQnWSS-xA8ubwO8WuUVhd7VpoLGCx5X4eh5Rt9nr4Pvy_zxnb-LD7bpO2XQWoETydU1UKxwqmU23TxPKwXfE-8d6mwoTo7HXBrM01D2kSkz44APeOGcu1MC5EV5Nm4XcvwEWOmRBSBdnHvmpRiNgsCiVoQoKX5u0hnXhUL2rfUUzWokY7TZYD4and7WmS5l-V2hgAN67_b6_uBlxrt9rk7cI3bsKKq2_B5e2WTHAbfg1rH_xhEnkGRDfHbkzaehVRtSXIuieNJ18V9jYx62Q2UeNxa4gGKPiNASPcxKDzTF8RRSZurqhqpV7wcpaTRvffvoPtbEHdvAOfz2X2d2G1bmp3H4h3VricJabwkrvSKmlsVmRFiYJsKbMDSDtsVKbVaseWIeOqV5mOeKoCnqqIpyoZwIv-msOFUsmZ1msdVqp21ZpVJ0AZwNN-OKw3WERStWuOgg0P-Vh4dCkGcG-B0P52WcazLBdhpFzCbm-AWubLI_XBt6hpjkqEaSn5ANY7mJ8817-n8eDsaTyBK5u726NqNNzZeghXGfKRIutqDVbn0yP3CC6ZH_OD2fRxdGQC--cN_z-uU4MP |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFD4aHZp44X4pDDASPDFriWMnMRJCwFZRbVQVArS34CtMapPRdky88MP4ddiuk6lM7G0PPPukidPv-PjkfP4OwFORZ1QaXmKWcYYpIwZzKSWmhguRcqWKUMH_vF-MRuXBAR-vwe_2LIynVbZrYliodaP8N_JtF6qTnPsOJNs20iLGO4NXR9-x7yDlK61tO40lRPbMzxOXvs1fDnfcf_2MkMHux7fvcOwwgBWj6QKLkhlSEJlKnSaauq2LtYm1OmXKRWorC6J1LqlLmQi3zhmoNURpKpkyLtKqNHO_ewnWC7fJoD1Yf7M7Gn_oahgFC62jvCCNS_fSPB7ZCQf3ghIe9qlbUGzHyWpYPLPXPUvZ_KtuG8Lh4Nr__CKvw9W4CUevl15zA9ZMfRM23keawS34Nayt85RpYCAg2ZyYCYqVLCRqjTwfHzUWfRW-64naQvOpmEyioTfwUuA-lLibKO9WsxdIoKlZCCyiCIy_nOSokd1XcWc7X5I6b8OnC5n9HejVTW3uAbJGM5OTRBWWU1NqwZXOiqwovVRbSnQf0hYnlYoq7r6ZyKTq9KcDtiqHrSpgq0r68Ly75mipYXKu9WaLmyquZ_PqFDR9eNINu5XIl5dEbZpjZ0NdpuYenbM-3F2itbtdltEsy5kbKVdw3Bl4lfPVkfrwW1A79xqFaclpH7ZayJ8-17-ncf_8aTyGDYf6an842nsAV4gnKgU61ib0FrNj8xAuqx-Lw_nsUfRqBF8uGv9_AG2wjSw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inflammatory+bowel+disease+and+risk+of+gastric%2C+small+bowel+and+colorectal+cancer%3A+a+meta-analysis+of+26+observational+studies&rft.jtitle=Journal+of+cancer+research+and+clinical+oncology&rft.au=Wan%2C+Qianyi&rft.au=Zhao%2C+Rui&rft.au=Xia%2C+Lin&rft.au=Wu%2C+Yutao&rft.date=2021-04-01&rft.pub=Springer+Berlin+Heidelberg&rft.issn=0171-5216&rft.eissn=1432-1335&rft.volume=147&rft.issue=4&rft.spage=1077&rft.epage=1087&rft_id=info:doi/10.1007%2Fs00432-020-03496-0&rft_id=info%3Apmid%2F33433655&rft.externalDocID=PMC11801894 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0171-5216&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0171-5216&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0171-5216&client=summon |